Chemours Co CC
The Chemours Company (herein referred to as “we”, “us”, or “our”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. 10-K, Item 1
- Employees
- 5,700
- Headquarters
- Wilmington, DE
- CEO
- Denise Dignam
- Next results
- around Feb 18, 2027
Where each dollar of revenue went, FY2024
Revenue of $5.8B through the costs to a net profit of $69.0M · income statement of the 10-K
CC among Materials peers
Six ratios from the latest 10-K. Each corner is the share of 84 peers the company is above, not a score.
What changed
19 new risk paragraphs. 10-K filed Feb 24, 2026 against Feb 18, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables -9.2% ($619.0M to $562.0M) vs revenue +0.4% ($5.8B to $5.8B), -9.7 pts apart
-
Cash from operations $264.0M vs net income −$386.0M (FY ending Dec 31, 2025)
-
Inventory +7.2% ($1.5B to $1.6B) vs revenue +0.4% ($5.8B to $5.8B), +6.8 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Evaluation of Per- and Polyfluoroalkyl Substances (PFAS) Environmental Remediation Liabilities; PFAS - Accrued Litigation Liabilities and Disclosures
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
19 paragraphs in Risk Factors that were not in the 10-K filed Feb 18, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 18, 2025 10-K, ITEM 1A
In March 2024, ECHA published a registration update for trifluoroacetic acid (“TFA”). This update includes a self-classification, by TFA registrants, of a Category 2 Reproductive toxicant. BAuA, the German competent authority responsible for REACH and the CLP regulation in Germany, submitted a dossier to ECHA proposing to harmonize the…
-
Item 1A · new paragraph · not in the 10-K filed Feb 18, 2025 10-K, ITEM 1A
In connection with the matters evaluated during the audit committee internal review in 2024, we have received inquiries and information requests from regulatory authorities and may be subject to additional investigations, enforcement actions, or other proceedings. Additionally, private plaintiffs have also initiated litigation, and…
-
Item 1A · new paragraph · not in the 10-K filed Feb 18, 2025 10-K, ITEM 1A
The current geopolitical environment has led to rapidly changing economic sanctions issued by the United States against individuals, entities and countries and resulted in countermeasures imposed by other jurisdictions. Failure to detect and abide by these changes could impact our reputation and results of operations, financial…
-
Item 1A · new paragraph · not in the 10-K filed Feb 18, 2025 10-K, ITEM 1A
The emergence, renegotiation, or expiration of FTAs and other international trade frameworks could adversely affect our competitiveness, supply chain, and financial results. The emergence of new FTAs, the renegotiation of existing FTAs, or the expiration or withdrawal of countries from such frameworks could adversely affect our global…
New risk paragraphs, against peers
Latest 10-K of each, Materials companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $6.8B | $6.1B | $5.8B | $5.8B |
| Net income | $578.0M | −$253.0M | $69.0M | −$386.0M |
| Operating cash flow | $755.0M | $556.0M | −$633.0M | $264.0M |
| Free cash flow | $448.0M | $186.0M | −$993.0M | $51.0M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$5.8B ▲ 0.4% in FY2025−$386.0M in FY2025$51.0M in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
10-QNov 5, 2026Quarterly report (10-Q) period ended Sep 30, 2026
-
10-KNov 3, 2026Annual report (10-K) (amended) period ended Dec 31, 2025
-
8-KNov 2, 2026Quarterly results 8-K item 2.02
About the company
Chemours Co, Wilmington, DE · from the 10-K filed Feb 24, 2026
The Chemours Company (herein referred to as “we”, “us”, or “our”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide (“TiO2”) pigment and industrial fluoropolymer resins.
- Headquarters
- Wilmington, DE
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Nov 2, 2026
- Incorporated in
- DE
Employees, at the top of the page: "As of December 31, 2025, we had approximately 5,700 employees globally, nearly all of which were full-time employees" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 18, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CC/export.csv") into a cell.